Capacetinib 160mg Capivasertib tablets 160mg x 64 tablets/box

Medication Safety Tips

Use this product according to its instructions, medical advice, and your health needs. Shipping is arranged after payment once the order meets dispatch requirements.

Contraindications

Warnings and Precautions
• Hyperglycemia: Regularly assess blood glucose levels before and during treatment. Suspend, reduce, or permanently discontinue LuciCapiva, depending on the severity.
• Diarrhea: LuciCapiva causes diarrhea in most patients. Patients are advised to add oral fluids to start diarrhea treatment and consult a physician if diarrhea occurs during LuciCapiva. Suspend, reduce, or permanently discontinue LuciCapiva, depending on the severity.
• Skin Adverse Reactions: Monitor for signs and symptoms of skin adverse reactions. Suspend, reduce, or permanently discontinue LuciCapiva, depending on the severity.
• Embryo-fetal toxicity: LuciCapiva can cause fetal harm. Patients are advised to be aware of potential risks to the fetus and to use effective contraception.

Medication risks

Adverse Reactions
The most common adverse reactions (incidence ≥ 20%), including laboratory abnormalities, are diarrhea, cutaneous reactions, random glucose increase, lymphopenia, hemoglobin decrease, fasting glucose increase, nausea, fatigue, leukopenia, triglyceride increase, neutropenia, creatinine increase, vomiting, and stomatitis.